发布文献求助

已入深夜，您辛苦了！由于当前在线用户较少，发布求助请尽量完整地填写文献信息，科研通机器人24小时在线，伴您度过漫漫科研夜！祝你早点完成任务，早点休息，好梦！

xiaoms

Lv2

110 积分 2026-03-16 加入

最近求助
最近应助
互助留言

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease 6小时前 待确认
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial 24天前 已完结
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial 24天前 已完结
Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists 1个月前 已关闭
[Expert consensus on the treatment of chronic rhinosinusitis with nasal polyps with biologics (2025)] 1个月前 已完结
Global Burden of Elevated LDL-C Findings From the Global Burden of Disease Study 2023 1个月前 已完结
系统性轻链型淀粉样变性诊疗中国指南 (2026年版) 1个月前 已关闭
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease 1个月前 已完结
Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective 2个月前 已完结
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors 2个月前 已完结

没有进行任何应助

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

Copyright © 2020-2026 AbleSci.COM, 科研通, All Right Reserved

科研通是非营利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

皖ICP备2024041134号-1

皖公网安备34019202002308

科研通【文献互助QQ群】：如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助，群号：821889395【点击一键加群】

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通